Akzo Nobel NV – Q3 2026 Outlook and Market Context
Akzo Nobel NV, the Dutch chemical and coatings group listed on both the NYSE and Euronext Amsterdam, announced its expectations for the quarter that ended 30 September 2026 on 21 October 2026. While the company has not yet released the formal audited results, analysts have offered consensus forecasts that illuminate the company’s recent performance trajectory.
Earnings‑per‑Share Forecast
- Consensus EPS for 3Q 2026: €1.13 per share (average of six analysts).
- Comparison to 3Q 2025: The company posted ‑€1.13 per share a year earlier, indicating a swing from a loss to a projected profit of roughly €2.26 per share in absolute terms.
- USD Conversion (for ADR investors): At a close price of €58.54 on 18 October 2026, the implied share price in USD is approximately $65.50. An EPS of €1.13 translates to about $1.26 per share, a modest improvement over the projected $0.446 for 3Q 2025 reported by a separate set of analysts.
The consensus view suggests that Akzo Nobel’s underlying profitability has recovered from a negative baseline, reflecting stronger margin performance in its decorative paints, surfactants, and polymer segments.
Revenue Outlook
- Projected Revenue for 3Q 2026: €2.60 billion (average of six analysts).
- Year‑over‑Year Growth: This represents a ~1 % increase over the €2.57 billion recorded in the same quarter of 2025.
- Analyst Expectation on Sales Trend: Five analysts forecast a modest 0.68 % decline in sales to $2.96 billion, highlighting a potential discrepancy in currency conversion or differing assumptions about the euro‑USD rate.
Overall, revenue is expected to remain relatively flat, suggesting that Akzo Nobel’s top‑line growth is under pressure from commodity price volatility and competitive pricing dynamics.
Market‑Level Context
- Current Share Price: €58.54 (18 October 2026).
- 52‑Week Range: €46.18 – €67.64, indicating that the share is trading near the lower half of its recent range.
- Price‑to‑Earnings Ratio: 15.67, positioning the stock at a moderate valuation relative to peers in the chemicals sector.
- Market Capitalisation: €9.99 billion, confirming Akzo Nobel’s status as a large‑cap material provider.
The company’s EPS recovery and modest revenue growth align with a broader trend in the chemicals industry, where firms are coping with input cost pressures while leveraging high‑margin specialty product lines. Akzo Nobel’s diversified portfolio—spanning decorative paints, surfactants, polymers, pulp and paper, bleaching & oxidising, and salt‑chlorine—provides a buffer against cyclical demand swings.
Bottom Line
Akzo Nobel’s consensus outlook for Q3 2026 signals a reversal from a loss in 2025 to a modest profit, supported by a slight uptick in revenue. The firm’s valuation remains within a comfortable range, and its earnings trajectory is improving, albeit with a flat revenue forecast that reflects current market headwinds. Investors will be attentive to the forthcoming audited figures, as they will confirm whether the consensus projections hold and whether the company can sustain momentum into the next quarter.
